Astera Labs, Inc. Common Stock

ALAB trades at a staggering P/E of 157.4, pricing in extraordinary growth expectations despite being just $25.4B in market cap—a valuation more typical of proven mega-cap winners. With RSI at 67.4, the stock sits in overbought territory, while the 11.11% short float suggests meaningful skepticism from sophisticated traders. Not currently at 52-week highs, yet the extreme multiple implies the market has already front-loaded years of outperformance into current pricing. This setup carries significant squeeze risk in either direction; any disappointment could trigger sharp mean-reversion, while a sustained loss of momentum may signal profit-taking from momentum-chasing buyers who anchored on hypergrowth narratives.